Comparison of RPL554 With Placebo and Salbutamol in Asthmatic Patients
Clinical trial NCT02427165 · COMPLETED
Trial details
- NCT number
- NCT02427165
- Sponsor
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-11-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.